Thermo Fisher Scientific will provide 50 units of the Ion Torrent Genexus System to support global collaborative Covid-19 research. Credit: NIAID-RML.

Thermo Fisher Scientific today has launched SARS-CoV-2 GlobalAccess Sequencing Program to speed up the national, multi-institutional efforts focussed on mapping Covid-19 transmission and epidemiological studies.

As part of the programme, which will available to research consortia and industry groups involved in the fight against pandemic, Thermo Fisher will offer 50 units of the Ion Torrent Genexus System at a subsidised price to support global collaborative Covid-19 research.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

This programme is intended to enable fast, real-time, sequencing-data acquisition and sharing through a network of decentralised institutions.

The access to SARS-CoV-2 sequencing data will allow researchers to understand how the virus is evolving. It will also help them with contact tracing and transmission interruption initiatives, and enable them to assist vaccine development programmes.

The Genexus System is a turnkey next-generation sequencing (NGS) solution. It is designed to provide results in a day with five minutes of hands-on time in a decentralised laboratory setting.

It allows laboratories with specimen-to-report workflow to conduct infectious disease studies using minimal amounts of sample.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thermo Fisher Scientific Life Sciences Solutions president and senior vice-president Peter Silvester said: “As we continue to support our customers by providing millions of Covid-19 tests each week, Thermo Fisher is increasing its efforts even further to accelerate the next phase of SARS-CoV-2 research with our next generation sequencing technology.

“The GlobalAccess Sequencing Program leverages our heritage of supporting infectious disease outbreaks and makes our newest platform more accessible to those who are working together around the world to help answer the important questions associated with the pandemic.”

Last month, Thermo Fisher rolled out AcroMetrix Coronavirus 2019 (Covid-19) RNA Control to monitor and validate Covid-19 molecular diagnostic tests.